AL
CMD

Airain Ltd’s Cantel Medical Corporation CMD Stock Holding History

Airain Ltd’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$201K Buy
+2,585
New +$194K 0.01% 758

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Airain Ltd's CMD Position: Q2 2017 in Review

Airain Ltd opened a new position in Cantel Medical Corporation (CMD) in Q2 2017: 2,585 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #758 among its holdings.

214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • Airain Ltd held 2,585 shares of Cantel Medical Corporation worth $201K as of Q2 2017.
  • Cantel Medical Corporation was a new Airain Ltd position in Q2 2017.
  • Cantel Medical Corporation made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #758 holding.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.